OR31-03 Testosterone Gender-affirming Hormonal Therapy Is Associated With Decreased Cerebral Blood Flow In Transgender Teens

Disclosure: S. Cote: None. K. Fathy: None. S. Lenet: None. O. Espinosa-Bentancourt: None. E. Lavallee: None. E. Croteau: None. D. Rottembourg: None. J. Lepage: None. K. Whittingstall: None. There is increasing demand for gender-affirming hormonal therapy (GAHT) in recent years, with increased access...

Descripción completa

Detalles Bibliográficos
Autores principales: Cote, Samantha, Fathy, Karim, Lenet, Stephanie, Espinosa-Bentancourt, Oscar-Esteban, Lavallee, Eric, Croteau, Etienne, Rottembourg, Diane, Lepage, Jean-Francois, Whittingstall, Kevin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Transgender Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554520/
http://dx.doi.org/10.1210/jendso/bvad114.2099

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554520/
http://dx.doi.org/10.1210/jendso/bvad114.2099

Ejemplares similares